Despite the consistent findings of low ZNF582-AS1 in multiple cancer sites and low expression associated with tumor progression, our understanding of the molecular mechanisms underlying the involvement of ZNF582-AS1 in cancer remains limited. The gene discussed is ZNF582; the disease is cancer.